Release Date: 11/05/11 16:35 Summary: Initial Substantial Shareholder Notice Price Sensitive: No Download Document 613.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%